Cargando…

Comparison of Risk Factors for Cholangiocarcinoma and Hepatocellular Carcinoma: A Prospective Cohort Study in Korean Adults

SIMPLE SUMMARY: Cholangiocarcinoma (CCA), especially intrahepatic cholangiocarcinoma, shares many of the commonly cited risk factors for hepatocellular carcinoma (HCC). Therefore, a common pathogenesis has been suggested for HCC and CCA; liver cirrhosis (LC) is considered a key factor in this “commo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, In Rae, Yi, Sang-Wook, Choi, Ja Sung, Yi, Jee-Jeon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997058/ https://www.ncbi.nlm.nih.gov/pubmed/35406481 http://dx.doi.org/10.3390/cancers14071709

Ejemplares similares

Sex-age-specific association of body mass index with all-cause mortality among 12.8 million Korean adults: a prospective cohort study
por: Yi, Sang-Wook, et al.
Publicado: (2015)

Body Mass Index and Cancer Mortality Among Korean Older Middle-Aged Men: A Prospective Cohort Study
por: Hong, Jae-Seok, et al.
Publicado: (2016)

Exophytic combined hepatocellular carcinoma and cholangiocarcinoma
por: Noh, Sang Jae, et al.
Publicado: (2012)

Clinicopathologic Study on Combined Hepatocellular Carcinoma and Cholangiocarcinoma: with Emphasis on the Intermediate Cell Morphology
por: Park, Ho Sung, et al.
Publicado: (2011)

Total cholesterol and all-cause mortality by sex and age: a prospective cohort study among 12.8 million adults
por: Yi, Sang-Wook, et al.
Publicado: (2019)

Low-normal hemoglobin levels and anemia are associated with increased risk of end-stage renal disease in general populations: A prospective cohort study
por: Yi, Sang-Wook, et al.
Publicado: (2019)

Clinicopathological characteristics and prognostic factors in combined hepatocellular carcinoma and cholangiocarcinoma
por: Park, Sang Eun, et al.
Publicado: (2013)

Impact of alcohol consumption and body mass index on mortality from nonneoplastic liver diseases, upper aerodigestive tract cancers, and alcohol use disorders in Korean older middle-aged men: Prospective cohort study
por: Yi, Sang-Wook, et al.
Publicado: (2016)

Contrast-enhanced ultrasound imaging features and clinical characteristics of combined hepatocellular cholangiocarcinoma: comparison with hepatocellular carcinoma and cholangiocarcinoma
por: Zhang, Hai-Chun, et al.
Publicado: (2020)

Total cholesterol and mortality from ischemic heart disease and overall cardiovascular disease in Korean adults
por: Kwon, Daeho, et al.
Publicado: (2019)

Comparison of Imaging and Clinically Relevant Features of Combined Hepatocellular Carcinoma and Cholangiocarcinoma with Hepatocellular Carcinoma
por: Huang, Xialing, et al.
Publicado: (2019)

Proteome Landscapes of Human Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Yi, Xiao, et al.
Publicado: (2023)

Pharmacogenetics of hepatocellular carcinoma and cholangiocarcinoma
por: Alonso-Peña, Marta, et al.
Publicado: (2019)

Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma
por: Yi, Sang-Wook, et al.
Publicado: (2019)

Prevalence and outcomes of extrahepatic primary malignancy associated with Hepatocellular Carcinoma in a Korean population
por: Hong, Sukho, et al.
Publicado: (2015)

Agent Orange Exposure and Prevalence of Self-reported Diseases in Korean Vietnam Veterans
por: Yi, Sang-Wook, et al.
Publicado: (2013)

Mixed Hepatocellular Cholangiocarcinoma: A Comparison of Survival between Mixed Tumors, Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma from a Single Center
por: Penzkofer, Lea, et al.
Publicado: (2023)

Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Massarweh, Nader N., et al.
Publicado: (2017)

Preoperative Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Nomogram Based on Ultrasonographic Features and Clinical Indicators
por: Chen, Yanling, et al.
Publicado: (2022)

Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or Cholangiocarcinoma
por: Murugesan, Karthikeyan, et al.
Publicado: (2021)

Aspirin Use and Risk of Hepatocellular Carcinoma in a National Cohort Study of Korean Adults
por: Hwang, In Cheol, et al.
Publicado: (2018)

Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Kis, Bela, et al.
Publicado: (2017)

CD44 expression in patients with combined hepatocellular cholangiocarcinoma
por: Kim, Ryounggo, et al.
Publicado: (2015)

Comparison of the clinical results of surgical resection for extrahepatic cholangiocarcinomas: Hilar cholangiocarcinoma and mid-to-distal cholangiocarcinoma
por: Jung, Pyung, et al.
Publicado: (2019)

Geographic Variation of Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma, and Hepatocellular Carcinoma in the United States
por: Altekruse, Sean F., et al.
Publicado: (2015)

Rapid progression of combined hepatocellular carcinoma and cholangiocarcinoma
por: Saboo, Sachin S., et al.
Publicado: (2011)

Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update
por: Roßner, Florian, et al.
Publicado: (2023)

Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and Cholangiocarcinoma
por: Ying, Fan, et al.
Publicado: (2023)

Association between fasting glucose and all-cause mortality according to sex and age: a prospective cohort study
por: Yi, Sang-Wook, et al.
Publicado: (2017)

Comparison of Cholangiocarcinoma and Hepatocellular Carcinoma Incidence Trends from 1993 to 2012 in Lampang, Thailand
por: Cao, Pianpian, et al.
Publicado: (2022)

A case of hepatoblastoma misdiagnosed as combined hepatocellular carcinoma and cholangiocarcinoma in an adult
por: Park, Keun Woo, et al.
Publicado: (2015)

Ileovesical Fistula Caused by Hepatocellular Carcinoma
por: Byun, Jeong Rae, et al.
Publicado: (2005)

Correlation of mutation and immunohistochemistry of p53 in hepatocellular carcinomas in Korean people.
por: Lee, Shi Nae, et al.
Publicado: (2002)

Contrast-enhanced ultrasound in association with serum biomarkers for differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma
por: Yang, Jie, et al.
Publicado: (2020)

Propensity-matched analysis of patients with intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing a liver transplant
por: Brandão, Ajacio Bandeira de Mello, et al.
Publicado: (2022)

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
por: Renzulli, Matteo, et al.
Publicado: (2021)

Proteomic Studies of Cholangiocarcinoma and Hepatocellular Carcinoma Cell Secretomes
por: Srisomsap, Chantragan, et al.
Publicado: (2010)

Staging and Prognostic Models for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Burkhart, Richard A., et al.
Publicado: (2017)

Gut dysbiosis in Thai intrahepatic cholangiocarcinoma and hepatocellular carcinoma
por: Pomyen, Yotsawat, et al.
Publicado: (2023)

Association between Proton Pump Inhibitor Use and Risk of Hepatocellular Carcinoma: A Korean Nationally Representative Cohort Study
por: Kim, Soungmun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_01o268alrjgt0d9d6tsf06sla3